WS13.3 Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international,randomized, double-blind,placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF) |